PepFellas Laboratories | Research-Grade Peptides
PEPFELLAS Laboratories • Est. 2026
Research Wiki / Peptide Profile
Peptide Profile

SS-31 (Elamipretide / MTP-131)

SS-31 (Szeto-Schiller 31), known generically as **Elamipretide** (and formerly Bendavia or MTP-131), is a synthetic, mitochondria-targeted tetrapeptide. SS-31 selectively concentrates on the inner mitochondrial membrane.

1. Chemical Structure and Biochemistry

SS-31 is a compact, cell-permeable peptide featuring an alternating aromatic-cationic amino acid motif.

  • Peptide Sequence: D-Arg-2',6'-dimethylTyr-Lys-Phe-$\text{NH}_2$
  • Structural Properties: The alternating positively charged (arginine, lysine) and aromatic (dimethyltyrosine, phenylalanine) residues allow SS-31 to cross both the plasma membrane and the outer mitochondrial membrane independently of mitochondrial membrane potential, accumulating up to 1,000–5,000-fold within the inner mitochondrial membrane.

2. Mechanism of Action

SS-31 operates directly at the biophysical architecture of mitochondrial bioenergetics.

  • Cardiolipin Stabilization: It binds selectively via electrostatic and hydrophobic interactions to cardiolipin, a unique anionic phospholipid found exclusively in the inner mitochondrial membrane that organizes respiratory supercomplexes (Complexes I–IV).
  • Bioenergetic Restoration: By preventing cardiolipin peroxidation and preserving cristae structure, SS-31 facilitates cytochrome $c$ electron transfer, increases ATP synthesis, reduces electron leakage (ROS production), and inhibits opening of the mitochondrial permeability transition pore (mPTP).

3. Research and Applications

Elamipretide has undergone extensive Phase 2 and Phase 3 clinical trials across mitochondrial and age-related degenerative diseases.

  • Primary Mitochondrial Myopathies & Barth Syndrome: Investigated clinically for rare genetic mitochondrial disorders characterized by defective cardiolipin remodeling, cardiomyopathy, and severe skeletal muscle fatigue.
  • Ophthalmology & Gerontology: Studied for dry age-related macular degeneration (geographic atrophy), heart failure, ischemia-reperfusion injury, and age-related cellular bioenergetic decline.
Tags: SS-31 Elamipretide MTP-131 Bendavia Szeto-Schiller-peptide cardiolipin mitochondria-targeted-peptide ATP-synthesis electron-transport-chain Barth-syndrome